Fluticasone Furoate/Vilanterol (Relvar)
Asthma / COPD
ApprovedCommercial
Key Facts
About KYORIN Pharmaceutical
KYORIN Pharmaceutical is a mid-sized, revenue-generating Japanese pharmaceutical company with a diversified portfolio spanning prescription drugs, over-the-counter (OTC) products, and veterinary medicines. The company leverages its expertise in respiratory and urological diseases to maintain a stable revenue base from commercial products while investing in R&D for future growth. Its strategic focus includes lifecycle management of key brands and advancing its pipeline through internal research and selective partnerships.
View full company profileTherapeutic Areas
Other Asthma / COPD Drugs
| Drug | Company | Phase |
|---|---|---|
| APG273 (Zumilokibart + APG333) | Apogee Therapeutics | Preclinical |